Secukinumab

Secukinumab - monoclonal antibody against IL-17 used for treatment of psoriasis. Article “Secukinumab” in Romanian Wikipedia has 35.7 points for quality (as of July 1, 2026). The article contains 44 references and 6 sections. The article also contains templates indicating quality issues, therefore its score was reduced by 1.88 points.

This article has the best quality in German Wikipedia. However, the most popular language version of this article is English.

Since the creation of article “Secukinumab”, its content was written by 1 registered users of Romanian Wikipedia and edited by 125 registered Wikipedia users in all languages.

The article is cited 2 times in Romanian Wikipedia and cited 863 times in all languages.

The highest Authors Interest rank from 2001:

• Local (Romanian): #18405 in December 2025
• Global: #50053 in March 2024

The highest popularity rank from 2008:

• Local (Romanian): #78941 in December 2025
• Global: #177254 in October 2024

There are 18 language versions for this article in the WikiRank database (of the considered 55 Wikipedia language editions).

The quality and popularity assessment was based on Wikipédia dumps from July 1, 2026 (including revision history and pageviews for previous years).

The table below shows the language versions of the article with the highest quality.

#	Language	Quality grade	Quality score
1	German (de) Secukinumab		63.7845
2	Greek (el) Σεκουκινουμάμπη		49.3952
3	English (en) Secukinumab		45.7182
4	Indonesian (id) Sekukinumab		43.8123
5	Hebrew (he) סקוקינומאב		41.7752
6	Korean (ko) 세쿠키누맙		36.5272
7	Romanian (ro) Secukinumab		35.7065
8	Vietnamese (vi) Secukinumab		32.5512
9	Chinese (zh) 司庫奇尤單抗		27.3674
10	Russian (ru) Секукинумаб		26.1787

More...

The following table shows the most popular language versions of the article.

The most popular language versions of the article "Secukinumab" in all the time

#	Language	Popularity award	Relative popularity
1	English (en) Secukinumab		765 854
2	German (de) Secukinumab		49 967
3	French (fr) Secukinumab		34 034
4	Japanese (ja) セクキヌマブ		19 834
5	Russian (ru) Секукинумаб		13 451
6	Portuguese (pt) Secuquinumab		7 383
7	Chinese (zh) 司庫奇尤單抗		5 839
8	Greek (el) Σεκουκινουμάμπη		5 579
9	Persian (fa) سکییوکروماب		4 550
10	Spanish (es) Secukinumab		3 377

More...

The following table shows the language versions of the article with the highest popularity in the last month.

The most popular language versions of the article "Secukinumab" in June 2026

#	Language	Popularity award	Relative popularity
1	English (en) Secukinumab		1 850
2	Chinese (zh) 司庫奇尤單抗		386
3	German (de) Secukinumab		379
4	French (fr) Secukinumab		91
5	Italian (it) Secukinumab		77
6	Russian (ru) Секукинумаб		67
7	Japanese (ja) セクキヌマブ		46
8	Polish (pl) Sekukinumab		44
9	Persian (fa) سکییوکروماب		31
10	Korean (ko) 세쿠키누맙		30

More...

The following table shows the language versions of the article with the highest Authors’ Interest.

Language versions of the article "Secukinumab" with the highest Authors Interest (number of authors). Only registered Wikipedia users were taken into account.

#	Language	AI award	Relative AI
1	English (en) Secukinumab		48
2	Hebrew (he) סקוקינומאב		14
3	German (de) Secukinumab		9
4	Japanese (ja) セクキヌマブ		8
5	Persian (fa) سکییوکروماب		7
6	Greek (el) Σεκουκινουμάμπη		6
7	French (fr) Secukinumab		6
8	Portuguese (pt) Secuquinumab		6
9	Spanish (es) Secukinumab		4
10	Italian (it) Secukinumab		3

More...

The following table shows the language versions of the article with the highest Authors’ Interest in the last month.

Language versions of the article "Secukinumab" with the highest AI in June 2026

#	Language	AI award	Relative AI
1	Arabic (ar) سيكيوكينيوماب		0
2	German (de) Secukinumab		0
3	Greek (el) Σεκουκινουμάμπη		0
4	English (en) Secukinumab		0
5	Spanish (es) Secukinumab		0
6	Persian (fa) سکییوکروماب		0
7	French (fr) Secukinumab		0
8	Hebrew (he) סקוקינומאב		0
9	Indonesian (id) Sekukinumab		0
10	Italian (it) Secukinumab		0

More...

The following table shows the language versions of the article with the highest number of citations.

Language versions of the article "Secukinumab" with the highest Citation Index (CI)

#	Language	CI award	Relative CI
1	English (en) Secukinumab		390
2	Italian (it) Secukinumab		167
3	Arabic (ar) سيكيوكينيوماب		121
4	Chinese (zh) 司庫奇尤單抗		60
5	Persian (fa) سکییوکروماب		45
6	Polish (pl) Sekukinumab		44
7	French (fr) Secukinumab		11
8	German (de) Secukinumab		7
9	Japanese (ja) セクキヌマブ		6
10	Russian (ru) Секукинумаб		4

More...

#	Language	Value
ar	Arabic سيكيوكينيوماب
de	German Secukinumab
el	Greek Σεκουκινουμάμπη
en	English Secukinumab
es	Spanish Secukinumab
fa	Persian سکییوکروماب
fr	French Secukinumab
he	Hebrew סקוקינומאב
id	Indonesian Sekukinumab
it	Italian Secukinumab
ja	Japanese セクキヌマブ
ko	Korean 세쿠키누맙
pl	Polish Sekukinumab
pt	Portuguese Secuquinumab
ro	Romanian Secukinumab
ru	Russian Секукинумаб
vi	Vietnamese Secukinumab
zh	Chinese 司庫奇尤單抗

Best Rank

Romanian: #78941 12.2025

Global: #177254 10.2024

Best Rank

Romanian: #18405 12.2025

Global: #50053 03.2024

On 1 July 2026 in multilingual Wikipedia, Internet users most often read articles on the following topics: 2026 FIFA World Cup, Kylian Mbappé, Erling Haaland, Democratic Republic of the Congo, FIFA World Cup, Harry Kane, Romelu Lukaku, Senegal, Michael Olise, Sadio Mané.

In Romanian Wikipedia the most popular articles on that day were: Republica Democratică Congo, Campionatul Mondial de Fotbal 2026, Senegal, Republica Congo, Campionatul Mondial de Fotbal, Societatea Română de Televiziune, Recordurile Campionatului Mondial de Fotbal, Lista finalelor Campionatului Mondial de Fotbal, Kylian Mbappé, România.

The WikiRank project is intended for automatic relative evaluation of the articles in the various language versions of Wikipedia. At the moment the service allows to compare over 50 million Wikipedia articles in 55 languages. Quality scores of articles are based on Wikipedia dumps from July, 2026. When calculating current popularity and AI of articles data from June 2026 was taken into account. For historical values of popularity and AI WikiRank used data from 2001 to 2026... More information